Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)

{ "Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Chronic Neck Pain", "This study is testing a treatment called Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) to see if it can help reduce chronic neck pain for military healthcare beneficiaries. Participants will receive either active PrTMS or a sham (inactive) version of the treatment. The main goal is to see if PrTMS reduces pain more effectively than the sham treatment, and to understand participants' experiences with the treatment. You may be able to join if you are a military healthcare beneficiary between 18 and 65 years old, and have had chronic neck pain for at least three months. The study is looking for 120 participants.", "design": "This interventional study plans to enroll 120 participants. It compares active Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) to a sham (inactive) version of the treatment.", "commitments": "You would receive 15 treatment sessions over 3-4 weeks, typically about 5 times a week. Your pain levels would be measured daily during treatment and then at 2, 4, and 8 weeks after treatment ends.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for up to 8 weeks after treatment ends to measure changes in their pain.", }

Study design: Not specified.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)

Recruiting

NAAges 18–65InterventionalTreatment

Henry M. Jackson Foundation for the Advancement of Military Medicine

~120 participants

Updated 2025-03-06 on ClinicalTrials.gov

What's tested:Personalized Repetitive Transcranial Magnetic StimulationSham Personalized Repetitive Transcranial Magnetic Stimulation

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Defense & Veterans Pain Rating Scale (DVPRS)

Measured over Measured to compare changes from Baseline; during Phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. Measurements taken everyday during Baseline, Phase 1 and Phase 2 and at 2, 4, and 8 weeks in Follow-Up

Conditions

Neck Pain

Where it's being run

1 sites across 1 states

Maryland1

Study leadership

Oluwaseyi Gbade-Alabi, MD · PRINCIPAL_INVESTIGATOR · Uniformed Services University of the Health Sciences

Who to contact

Oluwaseyi Gbade-Alabi, MD

[email protected]

240-688-7145

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Military health care beneficiary for enrollment.

Over the age of 18 years.

Presence of chronic neck pain for at least 3 months.

Exclusion

History of seizure, bipolar disorder, or schizophrenia.

Unstable heart or pulmonary disease.

Brain tumor, active brain infection, history of cerebral vascular accident (CVA), or penetrating brain injury.

Use of medications that potentially lower seizure threshold without concomitant administration of anticonvulsant drugs that may protect against seizure occurrence.

Not a suitable candidate for the study as determined by the PI.

Pregnancy, breastfeeding, or plans to become pregnant during the course of the study.

Presence of metallic hardware in close contact to the discharging coil (e.g. cochlear implants, internal pulse generator).

Presence of implanted brain electrodes (cortical or deep-brain electrodes).

Potential participants who score above a certain suicide relevant survey score on the Suicide Behaviors Questionnaire-Revised (SBQ-R), or are judged by expert clinicians to be a serious risk of harm to self, will be excluded.

Participants cannot have undergone a previous TMS treatment within the last 30 days before the start of study treatment.

Participants must have reliable and consistent access to the internet to complete surveys when not present in the clinic.

Participants must not have a clinical diagnosis of insomnia.

Participants can not be actively partaking in a substance abuse program.

What this trial measures

Defense & Veterans Pain Rating Scale (DVPRS)Measured to compare changes from Baseline; during Phase 1 and 2 of treatment; and during the follow up phase after treatment ends up to 8 weeks. Measurements taken everyday during Baseline, Phase 1 and Phase 2 and at 2, 4, and 8 weeks in Follow-Up
The DVPRS was developed to standardize pain measurement across all health care settings and promote pain assessment and reassessment practices. DVPRS is a visual pain scale to assess individual's pain intensity on a scale of 0-10, with an additional 4 questions to assess pain's interference with the participant's activity, sleep, mood, and stress. The scale has excellent internal reliability and test-retest reliability.

Trialytics